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Helicobacter pylori (H. pylori) is a gastrointestinal patho-
gen that has been linked to the development of chronic
gastritis, duodenal ulcer disease, and gastric cancer
[1–4]. Although the global average rate of infection is
near 60%, most individuals infected with H. pylori
remain asymptomatic. Nevertheless, gastric carcinoma
remains the second leading cause of cancer deaths world-
wide and H. pylori infection increases the risk of develop-
ing this disease [3,5–7]. However, the mechanisms by
which H. pylori contribute to the development and pro-
gression of gastrointestinal pathology are unclear.
There is significant genetic diversity among H. pylori
strains although bacteria that express the cytotoxin-asso-
ciated gene A pathogenicity island (cagPAI) and
virulence factors such as CagA are typically associated
with more severe disease manifestations [5,6,8,9]. The
cagPAI encodes a type IV secretion system (T4SS), which
translocates the CagA protein into the host cell where it
is phosphorylated [8,9]. In comparison with cagPAI
mutant or deficient strains, wild-type bacteria stimulate
activation of transcription factors such as NFjB and AP1.
CagPAI+ strains also show stronger activation of MAP
kinase signaling pathways [6,10,11]. Therefore, host cell
gene expression is modulated by components of the
T4SS- and possibly cagPAI-encoded virulence factors
such as CagA. Furthermore, genetic variations among
H. pylori species might account for the highly variable
consequences of H. pylori infection in humans [12].
In addition to gastritis and gastric atrophy, hypergas-
trinemia is observed in a subset of H. pylori-infected
patients [13–15]. However, there are few studies
examining H. pylori regulation of human gastrin gene
expression in vivo or in primary human G cells. Calam
and coworkers showed that patients infected with
H. pylori increased gastrin mRNA levels [16], whereas
Sumii et al. [17] reported no change in gastrin mRNA.
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Abstract
Background: Helicobacter pylori (H. pylori) infection has been linked to the
development of chronic gastritis, duodenal ulcer disease, and gastric cancer.
Helicobacter pylori- infected patients and animal models develop hypergastri-
nemia, chronic gastritis, and gastric atrophy. Since gastrin is an important
regulator of gastric acid secretion and cell growth, H. pylori regulation of this
hormone has been implicated in its pathogenesis.
Objectives: To investigate the effect of H. pylori on gastrin gene expression
in mice and of human bacterial isolates on gastrin mRNA expressed in a
human cell line.
Methods: Gastrin mRNA was measured by qRT-PCR in H. pylori-infected
mice. H. pylori were co-cultured with AGS cells to study regulation of
human gastrin gene expression. Various MAP kinases were implicated in sig-
nal transduction from the bacteria using specific inhibitors. Gastrin reporter
constructs and gel shift assays were used to map DNA responsive elements.
Results: In addition to an increase in gastrin mRNA in H. pylori-infected
mice, H. pylori induced the endogenous human gastrin gene through MAP
kinase-dependent signaling but not NFjB-dependent signaling. Activation of
gastrin through MAPK signaling did not require CagA or VacA virulence fac-
tors. Transfection studies demonstrated that a GC-rich motif mediated
H. pylori-induction of the gastrin promoter and that the motif inducibly
binds Sp1 and Sp3 transcription factors.
Conclusions: Direct contact of live H. pylori bacteria with human cells is suf-
ficient to induce gastrin gene expression.
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Buchan and coworkers reported that H. pylori increases
basal levels of gastrin in primary G-cell cultures, but
does not induce secretion, suggesting that H. pylori
increases gastrin synthesis and possibly gene expression,
but mRNA levels were not measured [18].
Similarly in several rodent models of H. pylori infec-
tion, the number of antral G cells increase coincident
with elevated serum gastrin levels [19,20]. Antral
gastrin is the primary hormonal regulator of gastric acid
secretion. Furthermore, gastrin acts as a growth factor
for gut-derived cell types. The essential role of gastrin in
acid regulation and maintenance of gastric homeostasis
suggests possible mechanisms by which H. pylori might
alter gastrointestinal physiology by regulating the levels
of gastrin. As Helicobacter infection inhibits acid secretion
[21], the observed hypergastrinemia might be in
response to the hypochlorhydria. Indeed, direct inhibi-
tion of acid secretion by omeprazole is sufficient to stim-
ulate gastrin gene expression in vivo [22]. Prior studies
suggested that Helicobacter colonizing the gastric antrum
might create an alkaline pH sufficient to stimulate G
cells through its production of urease and conversion of
urea to ammonia [23]. However, this mechanism was
subsequently disproven by studies showing that H. pylori
products rather than the live organism can stimulate
gastrin release from cultured G cells [24,25]. These
results suggest that cellular components even from dead
bacteria are sufficient to stimulate hormone release.
Recent studies by Kidd et al. [26] demonstrate that
multiple extracellular signals, e.g., pH, lipopolysacchar-
ide (LPS), serotonin, b-adrenergic receptors and
intracellular pathways, e.g., cAMP, ERKs (extracellular
signal-regulated kinase-1), NFjb, regulate gastrin release
from primary G cells. However, the authors did not
examine regulation of gastrin gene expression in
response to these various conditions. Although suppres-
sion of somatostatin is the strongest inducer of gastrin
release, we found that pro-inflammatory cytokines were
able to stimulate gastrin release in the somatostatin null
mouse demonstrating that extracellular signals other
than somatostatin are capable of inducing gastrin
secretion [27]. Taken together, it is unclear whether the
hypergastrinemia that occurs in H. pylori-infected
individuals is attributable to hypochlorhydria, suppres-
sion of somatostatin, chronic gastritis, gastric atrophy or
the direct induction of gastrin gene expression by the
bacteria itself. Certainly, several mechanisms are likely
to contribute to the increase in plasma gastrin.
It has been shown using cell lines that oncogenic K-ras
and epidermal growth factor (EGF) receptor ligands
induce gastrin gene expression [28–30]. Indeed, a gastrin
EGF response element (gERE) was mapped to a GC-rich
sequence within the first 240 bp of the gastrin promoter.
This proximal promoter element binds the transcription
factors Sp1, Sp3, and ZBP-89 [31]. Moreover, we showed
previously that Mek1-dependent phosphorylation of Sp1
mediates EGF activation of the gastrin promoter through
this element [32]. It has been established in numerous
studies that H. pylori and possibly bacterial proteins such
as CagA regulate gene expression through activation of
signal transduction cascades that target specific transcrip-
tion factors. Furthermore, a prior study established a
MEK ⁄ ERK-dependant mechanism for the activation of
both Sp1 and Sp3 in the H. pylori-mediated induction of
the vascular endothelial growth factor-A (vegf-A) gene
[33]. Therefore, we tested the hypothesis that H. pylori
regulate gastrin gene expression through specific DNA
promoter elements that bind Sp1.
Methods
Helicobacter Strains and Cultures
The 26695 and SS1 H. pylori WT and mutant strains were
generated as previously described [34]. The J99 strain
was obtained from ATCC. All H. pylori strains were grown
on blood agar plates prior to inoculation of Brucella broth
(Difco , Livonia, MI) supplemented with 10% heat-
inactivated fetal bovine serum (FBS), Skirrow’s antibiotic,
and amphotericin B. H. pylori cultures were maintained
by shaking in a gas exchange incubator under microaero-
philc conditions at 37 C. The broth used for infection
was cultured overnight. The presence of H. pylori was
verified biochemically by catalase and urease tests as well
as microscopic analysis for size, shape, and motility.
In vivo H. pylori Infection in Mice
Six- to 8- week-old C57BL ⁄ 6 mice were orally inocu-
lated once with 1 · 108 CFU of broth-cultured H. pylori,
strain SS1, in 0.1 mL of broth. Control mice were not
given bacteria. Mice were killed 6 months after inocula-
tion, and gastric tissue was collected for histologic exami-
nation, PCR, and qRT-PCR analysis. Gastric RNA was
harvested from mucosal scrapings of the whole stomach
using TrIzol reagent (Invitrogen, Carlsbad, CA) according
to the manufacturer’s instructions. Purification of mRNA
was accomplished using the Qiagen’s RNeasy MiniKit
(Qiagen, Valencia, CA) and stored at )80 C. Generation
of cDNAs was performed using the Invitrogen Super-
Script First Strand kit and random hexamer primers.
Quantitative Real-Time PCR (qRT-PCR)
Total RNA was isolated from AGS cells [human gastric
adenocarcinoma cell line (ATCC, Manassas, VA)] using
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Trizol reagent (Invitrogen) and DNAse treated (Roche,
Indianapolis, IN). RNA quantitation was performed using
the Quant-iT RiboGreen RNA Assay Kit (Molecular
Probes, Eugene, CA). Synthesis of cDNA was performed
for 1 lg of mouse and human RNA using the I-script
cDNA Synthesis Kit (Bio-Rad, Hercules, CA).
All qRT-PCR reactions were preformed in triplicate
using the Bio-Rad I-cycler. The following primers were
used to detect and quantify gene expression: mouse
gastrin: (forward) ACACAACAGCCAACTATTC, (reverse)
CAAAGTCCATCCATC CGTAG. Mouse GAPDH: (for-
ward) TCAAGAAGGTGGTGAAGCAGG, (reverse) TATT-
ATG GGGGTCTGGGATGG. Human gastrin (forward)
CCCAGGCTCTCATCATCGAAGG, (reverse) GCCGAAGT
CCATCCATCCATAGG. Human 18S rRNA: (forward)
GATATGCTCAT GTGGTGTTG, (reverse) AATCTTCTTCA-
GTCGCTCCA [35]. Human IL-8: (forward) TAGCAAAA
TTGAGGCCAAGG, (reverse) AAACCAAGGCACAGTGG
AAC.
Reactions using mouse RNA and primers were
performed at a volume of 20 lL and contained the follow-
ing: 1· reaction buffer, 5.5 mmol ⁄ L MgCl2, 100 nmol ⁄ L
of forward and reverse primers, 10 nmol ⁄ L fluorescein,
200 lmol ⁄ L dNTPs, SYBR green, and 0.025 units of Plati-
num Taq polymerase (Invitrogen). Amplification was
performed under the following conditions: 3 minute at
95 C, 35–40 cycles of 9 seconds at 95 C and 1 minutes
at 60 C, and 1 minutes at 55 C. Expression of mouse
target genes was normalized to GAPDH.
Reactions using human primers were performed at a
volume of 20 lL and contained the following: 1· reac-
tion buffer, 1.5 mmol ⁄ L MgCl2, 100 nmol ⁄ L of forward
and reverse primers, 10 nmol ⁄ L fluorescein, 200 lmol ⁄ L
dNTPs, SYBR green, and 0.025 U of Amplitaq Gold poly-
merase (Applied Biosystems, Carlsbad, CA). Reactions
were performed with the following conditions: 50 C for
2 minutes and 95 C for 10 minutes followed by 40
cycles of 95 C for 15 seconds and 60 C for 1 minutes.
Gene expression was normalized to 18s rRNA. Expres-
sion of human target genes was normalized to 18s
rRNA. The fold change for all reactions was calculated
using the following equation (Ct)Cthi) = ntarget gene,
2ntarget ⁄ 2nnormalization.
Cell Culture
AGS cells (human gastric adenocarcinoma) were grown
in DMEM (Gibco-BRL) containing 10% FCS, 100 lg ⁄ mL
penicillin, and 100 lg ⁄ mL streptomycin at 37 C with
5% CO2. The cells were serum starved for 48 hour in
serum-free HAMS ⁄ F12 media [Gibco (Invitrogen)
Carlsbad, CA] prior to any treatment or co-culture with
H. pylori.
Plasmids and Constructs
To generate the pGL3 gastrin reporter constructs, seg-
ments from )3.3 to )0.190 kb of the human gastrin
promoter were ligated into the pGL3 basic luciferase
vector (Promega, Madison, WI). Gastrin promoter frag-
ments from )2.3 to )0.19 kb were isolated by restric-
tion digest from the )3.3 kb gastrin proximal promoter
fragment. Site-directed mutations were introduced into
the )0.240- kb construct using the QuickChange II Kit
(Stratagene). Primers designed to introduce mutations
were generated using the primer design application on
the Stratagene website. All constructs were confirmed
by sequence analysis. Several rounds of single mutation
reactions were performed to generate constructs with
mutations in multiple sites. The activity of the Path
Detect pAP1-Luc Cis-Reporter Plasmid (Stratagene) was
used as a positive control for activation by H. pylori
observed in the transfection experiments.
Transient Transfections and Luciferase Reporter
Assays
AGS cells were seeded onto 12- or 24-well plates and
grown to 50–60% confluency prior to transfection.
Plasmid DNA at concentrations of 0.5–1 lg ⁄ well was
transfected using Fugene 6 (Roche) according to the
manufacturer’s protocol. The promoterless phRG-B
Renilla luciferase reporter (Promega) served as a trans-
fection control to normalize firefly luciferase activity.
The cells were treated then harvested at 48 hour after
transfection. Firefly and Renilla luciferase were mea-
sured using the Dual Luciferase Assay Kit (Promega).
H. pylori Co-culture with AGS Cells
AGS cells were seeded at 50–75% confluency and
cultured in serum-free media containing antibiotics for
48 hour prior to H. pylori inoculation. H. pylori were
quantified then resuspended in F12 media without
antibiotics. The AGS cells were washed with PBS and
maintained in serum-free and antibiotic-free media for
the duration of the co-culture experiments with H. pylori.
Western Blot Analysis
Whole cell extracts were generated from AGS cells that
were cultured in serum-free media 48 hour prior to
treatment with chemical inhibitors and H. pylori
co-culture. Cell pellets were lysed with M-PER
Mammalian Protein Extraction Reagent (Pierce, Rock-
ford, IL) containing complete protease inhibitor tablets
(Roche) according to the manufacturer’s instructions.
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The protein concentration for each sample was
determined using the bicinchoninic acid assay (Pierce
Biochemicals). Protein lysates were resolved on 4–20%
SDS–polyacrylamide gradient gels then transferred to
Hybond-C Extra nitrocellulose membranes (Amersham,
Piscataway, NJ). Membranes were blocked using KPL
blocking solution (KPL, Inc, Gaithersburg, MD, USA).
Primary antibodies for GAPDH (Millipore, Bedford, MA),
ERK1 ⁄ 2 (Cell Signaling, Beverly, MA), p38 (Cell
Signaling), Sp1 (Santa Cruz Biotechnology, Santa Cruz,
CA), and Sp3 (Santa Cruz Biotechnology) were used at a
concentration of 1 : 1000. Phospho-antibodies against
p38 (Cell Signaling), ERK1 ⁄ 2 (Cell Signaling), and cJun
(Cell Signaling) were used at a 1 : 500 concentration.
Proteins were visualized using HRP-conjugated second-
ary antibodies and ECL reagent from the SuperSignal
West Pico Chemiluminescent Kit (Thermo Fischer
Scientific, Pittsburgh, PA).
Electrophoretic Mobility Shift Assays (EMSA)
Nuclear extracts were prepared using non-ionic deter-
gent extraction from AGS cells following co-culture
with H. pylori for various times. Oligonucleotide probes
were designed according to regions of the human gas-
trin promoter. An AP1 binding oligo was designed
using two consecutive API binding sites (TGCATCA ·
2) and used as a positive control for H. pylori-induced
DNA binding. All oligos were flanked by BamHI and
Bgl II sequences at the 5¢ and 3¢ ends, respectively,
annealed then labeled with [32P] c-ATP using polynu-
cleotide kinase (Roche). Gel shift assays were carried
out at a final volume of 20 lL and contained
10 mmol ⁄ L Tris–HCl, 1 mmol ⁄ L EDTA, 1 mmol ⁄ L DTT,
5 mmol ⁄ L MgCl2, 1 mmol ⁄ L ZnCl2, 150 mmol ⁄ L KCl,
10% glycerol, and 300 ng polydI-dC. One microgram
of antibodies against Sp1 or Sp3 antibodies (Santa Cruz
Biotechnology) were used for gel shift assays to iden-
tify DNA binding proteins. One microliter of labeled
probe at 30,000 cpm ⁄ lL was added to each reaction.
DNA complexes were resolved on a 6% nondenaturing
polyacrylamide gel containing the 45 mmol ⁄ L Tris
base, 45 mmol ⁄ L boric acid, 1 mmol ⁄ L EDTA (TBE)
buffer.
Chemical Inhibitors
Inhibitors were added to cells 30 minutes prior to
co-culture with H. pylori. The following inhibitors were
used: a-amanitin (Sigma), PD98050 (Cell Signaling
Technology), ammonium pyrrolidinedithiocarbamate
(APDT, Calbiochem), SB203580 (Calbiochem), and
SP600125 (Calbiochem).
Statistics
Data were compared using the Mann–Whitney U test.
The mean ± standard error of the mean (SEM) is shown.
A p value of <0.05 (*) was considered significant.
Results
H. pylori Infection Induces Gastrin Gene
Expression in Mice
In human subjects and animal models, H. pylori infection
is associated with chronic gastritis and hypergastrinemia.
However, increases in plasma gastrin and the population
of G cells have not been consistently correlated with
changes in gastrin gene expression [16,17]. Therefore,
we studied gastrin gene expression in a mouse model of
H. pylori infection. C57BL ⁄ 6 mice were infected with the
mouse-adapted SS1 strain of H. pylori and harvested
after 6 months. Persistence of the bacterial infection was
confirmed by PCR amplification of the bacterial 16S
gene. Using quantitative PCR, a 10-fold increase in gas-
trin mRNA was observed in mice infected with H. pylori
when compared to uninfected controls (Fig. 1). The
observed increase in gastrin mRNA expression suggested
that infection by H. pylori correlated with an increase in
gastrin gene expression. Because a direct effect of the
bacteria on the G cell cannot be established in vivo, we
utilized a human AGS gastric cell line to characterize the
effect of H. pylori on gastrin gene expression.
Gastrin mRNA Induction Requires Live Bacteria,
but not CagA
We examined the ability of H. pylori to regulate














Figure 1 Helicobacter pylori stimulate gastrin gene expression in
infected mice. Mice were infected with H. pylori SS1and analyzed
6 months after infection. qRT-PCR analysis of gastrin normalized to
GAPDH (Gastrin mRNA) was performed using RNA isolated from the
stomachs of infected and uninfected (—) mice (N = 5 mice). The mean
is indicated by a bar. *p < .05.
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qRT-PCR. Cells were co-cultured with the 26695
H. pylori strain, which is a wild-type human isolate
[36]. The endogenous human gastrin gene was maxi-
mally induced 6- to 7-fold by 9 hour (Fig. 2A) with the
maximal 100 m.o.i. (Fig. 2B).
After establishing the optimal conditions for gastrin
induction, we investigated whether live bacteria were
required for the effect. AGS cells were co-cultured with
live H. pylori or bacteria that was heat-inactivated and
formalin-fixed. Indeed, we found that killed bacteria
were unable to induce gastrin mRNA expression
(Fig. 2C). Similar results were observed using the SS1
strain under the same conditions (data not shown).
In H. pylori-infected patients, there is significant vari-
ability in the clinical outcome that is often associated
with the genetic variations between H. pylori strains.
Similarly, laboratory studies have indicated that
cagPAI+ and CagA+ strains influence the ability of
H. pylori to regulate gene expression and activate
specific signal transduction pathways. Therefore, we
investigated whether there were differences among
H. pylori strains that might influence their ability to
induce the gastrin gene. AGS cells were co-cultured
with three wild-type strains 26695, J99 as well as the
SS1 strain, all of which contain complete cagPAI [37],
despite the prevailing view that the SS1 cagPAI is dys-
functional. Moreover, we examined gastrin gene
expression following co-culture with 26695 isogenic
mutants that lacked the CagA and vacuolating toxin A
(VacA) gene with AGS cells. All the H. pylori induced
gastrin mRNA expression. Higher levels were observed
with the CagA- and VacA-deficient strains as well as
the SS1 strain (Fig. 2D). As the VacA-deficient strain
showed levels of gastrin induction comparable to those
of the CagA-deficient and SS1 strains, we concluded
that the increased activation of gastrin mRNA is not
influenced directly by either CagA or VacA but may be
the result of other bacterial proteins.
Induction of Gastrin Requires Activation of MAPK
Signaling
It has been shown previously that H. pylori activate
multiple signaling pathways including MAP kinase,
NFjB, and PI3K [38]. Therefore, AGS cells were treated
with chemical inhibitors of the ERK, JNK and p38 MAP
kinases (MAPK) to identify the signal transduction
pathways activated by H. pylori. AGS cells were
pretreated for 30 minutes with inhibitors and then
co-cultured with H. pylori for 9 hour (Fig. 3A). ERK
and p38 inhibitors completely blocked gastrin induction
by H. pylori whereas the JNK inhibitor blocked H. pylori
induction by 50%. Although H. pylori clearly activate
NFjB signaling [39,40], inhibiting this pathway with
APDT did not block induction of the gastrin gene. To
confirm that the inhibitors blocked the activation of
ERK, cJun, and p38 MAPKs, Western blots were
performed and demonstrated that the doses of the
inhibitors were sufficient to block activation of these
signaling pathways (Fig. 3C). Moreover, the dose of
APDT inhibited NFjB-mediated induction of IL-8 gene
expression (Fig. 3B) [41]. Thus, we concluded that
H. pylori induction of the human gastrin gene is medi-
ated by MAPK rather than through NFjB signaling.
H. pylori Stimulates Transcriptional Initiation of
Gastrin mRNA
To determine whether the induction of gastrin by




































































Figure 2 Helicobacter pylori stimulate expression of gastrin in AGS
Cells. AGS cells were infected with H. pylori strain 26695 (a human
isolate) 48 hour after serum starvation. The cells were cultured with
bacteria at a m.o.i of 100–1 at various times (A) or with increasing
amounts of bacteria (m.o.i) for 9 hour (B). All subsequent H. pylori
co-culture experiments were performed at 100:1 m.o.i. for 9 hour.
AGS cells were co-cultured with live or inactive (formalin fixed,
heat-treated) bacteria (C). qRT-PCR analyses of gastrin and 18S rRNA
transcripts were performed on total RNA, and the amount of gastrin
mRNA was normalized to 18S rRNA (Gastrin mRNA). All samples were
compared to the untreated sample that was set to 1. The mean fold
change ± SEM is shown for three independent experiments. *p < .05
compared to untreated cells was considered significant. (D) AGS cells
were co-cultured with the wild-type H. pylori strain 26695 (WT), or
isotypes mutants of 26695 that were null for CagA (-CagA) or VacA
(-VacA). Two additional human Hp isolates were also used, the wild-
type J99 strain and the mouse-adapted SS1 strain. qRT-PCR analyses
of gastrin and 18S rRNA transcripts were performed. Gastrin mRNA
was normalized to the 18S transcript. The mean fold change ± SEM
three experiments is shown. *p < .05 compared to untreated cells
was considered significant.
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AGS cells were pretreated with the RNA polymerase
inhibitor a-amanitin for 30 minutes prior to co-cultur-
ing with the bacteria. The basal expression of gastrin
was not affected by 0.1, 0.5, or 1 lmol ⁄ L of a-amanitin
(data not shown). However, treatment with 1 lmol ⁄ L
a-amanitin completely blocked H. pylori -induced gas-
trin gene expression when the cells were co-cultured
with the 26695 strain (Fig. 3D). Similar results were
obtained using the SS1 strain (data not shown). There-
fore, we concluded that H. pylori induce gastrin by stim-
ulating transcriptional initiation rather than by
increasing mRNA stability.
H. pylori Stimulates Gastrin Expression through
GC-rich DNA Elements
To identify the H. pylori-responsive element within the
human gastrin promoter, we generated a series of
luciferase constructs representing the sequences
between )3.3 and )190 bp of the gastrin promoter
(Fig. 4A). The basal activity of each reporter construct
is shown as relative light units and indicated that the
highest basal activity was within the first 240 bp of the
promoter as previously reported (Fig. 4B) [42]. Tran-
sient transformants of AGS cells expressing the various
gastrin reporters were co-cultured with H. pylori. We
observed a significant induction of promoter activity
for all gastrin promoter constructs from )3.3 to
)0.24 kb (Fig. 4C). However, when the 43 bp region
between )240 and )190 bp was deleted, there was a
30% decrease in promoter activation suggesting the
presence of an H. pylori responsive element contained
within this region. AGS cells expressing an AP1
luciferase reporter were significantly induced when
co-cultured with H. pylori. This induction is consistent
with prior studies demonstrating the ability of H. pylori
to activate target genes through AP1 DNA elements.
To validate that the decrease in gastrin promoter acti-
vation was attributable to an H. pylori-specific effect,
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Figure 3 MAP kinase inhibitors block Helicobacter pylori-induced gastrin expression. AGS cells were treated with vehicle alone (—) or with chemi-
cal inhibitors of ERK, JNK, and p38 MAP kinases, respectively (PD98059: 50 lmol ⁄ L, SP600125: 10 lmol ⁄ L, SB203580: 10 lmol ⁄ L) or NFjB (APDT:
10 lmol ⁄ L) signaling 30 minutes prior to co-culture with the H. pylori 26695 strain (Hp). qRT-PCR analysis of gastrin transcripts (A) or IL-8 tran-
scripts (B) were normalized to 18S rRNA. The mean fold change ± SEM three experiments is shown *p < .05 compared to untreated (—) cells.
Western blots were performed on whole cell extracts prepared from cells cultured without (—) or with (+) H. pylori ± the indicated inhibitors (C).
(D) AGS cells were treated without (—) or with 1 lmol ⁄ L a-amanitin prior to co-culture with the H. pylori 26695 strain. Gastrin mRNA normalized
to 18S rRNA transcripts was determined by qRT-PCR of total RNA. The mean fold change ± SEM for three experiments is shown. *p < .05
compared to untreated cells. APDT, ammonium pyrrolidinedithiocarbamate.
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There was no difference in PMA-induced promoter
activity between the )240- and )190- bp promoter
constructs suggesting that the region contained an
H. pylori -specific response element. A significant
reduction in the PMA-induced activity of the )2.3- kb
reporter did not show a difference in Hp-induced activ-
ity. Therefore, we concluded that this DNA segment
contained a regulatory region associated with induction
by PMA and not H. pylori.
Upon examination of the region between )240 and
)190 bp, we identified two cytosine-rich sites as puta-
tive H. pylori responsive elements (C2AC4 = GC-rich)
(Fig. 5A, Site 1). However, because the )190- bp
construct retained the ability to be induced by H. pylori
(4-fold), additional downstream promoter sequences
containing a GC-rich motif at )120 bp and the reverse
complement at )74 bp were also evaluated (Fig. 5A,
sites 2 and 3).
To determine whether the GC-rich elements were
required for H. pylori induction, point mutations were
introduced to disrupt protein binding at these elements
(Fig. 5A). The results showed that mutating the GC-
rich elements within site 1 or sites 2 and 3 together
increased the basal activity compared to that of the
wild-type reporter (Fig. 5B). The introduction of other
point mutations did not alter basal activity. Mutations
of site 1 reduced gastrin promoter activation when
H. pylori were co-cultured with cells transfected with
WT or mutant reporters (Fig. 5C). This result was com-
parable to the decrease in activity observed with a
deletion between )240 and )190 bp (30%). In addi-
tion, decreased activation was also observed with
mutation of site 3 alone and mutation of site 1 with
either site 2 or 3. There was no effect on the activation
gastrin reporters when site 2 alone was mutated. The
mutation of sites 2 and 3 together caused a slight
decrease in H. pylori-induced activity. However, the
mutation of sites 1, 2, and 3 together resulted in the
greatest suppression in H. pylori activation (from 6.5 to
2-fold, Fig. 5C). Therefore, we concluded that the
GC-rich elements between )240 and )190 were
required for maximal activation of the gastrin promoter
by H. pylori.
H. pylori Induce Sp1 ⁄ Sp3 Protein Binding to GC-
rich DNA Elements
Next, we identified the nuclear proteins binding to the
specific GC-rich sites by electrophoretic mobility shift
assay. We determined that the two major complexes
binding these elements were transcription factors Sp1
and Sp3 (Fig. 6). We observed increased protein bind-
ing activity in extracts from H. pylori-treated cells to the
)228 and )120 probes (Fig. 6, lanes 1, 2, 5 and 6).
However, Sp1 binding to the )74 element remained
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Figure 4 Helicobacter pylori stimulate the proximal gastrin promoter. AGS cells were transiently transfected with the empty vector (pGL3), a
series of gastrin luciferase constructs, or an AP1 luciferase reporter (pAP1-Luc). A schematic representation of the gastrin luciferase constructs is
shown (A). The basal activity of the gastrin constructs is shown as relative light units (RLU) of the firefly normalized to the Renilla luciferase activity
(B). Cells were co-cultured with H. pylori (C) or 100 nmol ⁄ L PMA (D) 48 hour post-transfection. The mean fold change ± SEM for three separate
experiments was performed in triplicate. The filled bar represents the baseline expression in RLU for each construct set to 1, and fold changes
were the ratio of the stimulated activity compared to basal expression of each construct.
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treatment (Fig. 6, lanes 9 and 10). By contrast, AP1
protein binding increased consistent with prior studies
(Fig. 6, lanes 13 and 14) [43,44].
Discussion
In this study, we demonstrated that the increase in gas-
trin mRNA initiated by an H. pylori infection is because
of the transcriptional initiation. We used the AGS cell
line to show that gastric cells can respond directly to the
bacteria alone. It has been widely reported that the
number of G cells and the release of gastrin increases
during H. pylori infection in human subjects and various
animal models [19,45,46]. Indeed, we also observed that
gastrin gene expression was higher in H. pylori-infected
mice when compared to uninfected mice. Yet, few stud-
ies have actually examined whether the increase is
related to induction of gastrin gene expression as
opposed to an increase in secretion of the hormone.
Moreover, the cell line experiments were important to
perform to distinguish between a direct induction of
human gastrin gene expression by bacteria versus recep-
tor-mediated activation by pro-inflammatory cytokines.
Separating these two events is impossible to achieve in
vivo in human subjects or mouse models prompting our
use of a human cell line and human isolates of H. pylori.
Although nearly pure rat G-cell cultures have been used
to study gastrin release [26], transfecting these primary
cells with various constructs still remains problematic.
We found that H. pylori alone effectively induced the
endogenous human gastrin gene. Furthermore, no
induction was observed when the cells were co-cul-
tured with dead bacteria, which underscores the
requirement for viable bacteria. H. pylori virulence
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Figure 5 Helicobacter pylori stimulate the gastrin promoter through
GC-rich DNA elements. AGS cells were transiently transfected with the
wild-type (WT) 240- bp gastrin luciferase reporter or the reporter
containing point mutations at the indicated sites (S1, 2, 3). Altered
nucleotides are shown in bold font (A). The basal activity of gastrin
constructs is shown as relative light units (RLU) of firefly to Renilla
activity (B). The cells were co-cultured with H. pylori 48- hour post-
transfection (C). The mean fold change ± SEM for three separate
experiments was performed in triplicate. The filled bar represents the
baseline expression in RLU for each construct set to 1 and fold
changes were the ratio of the stimulated activity compared to basal
expression.







































Figure 6 Helicobacter pylori stimulate binding of Sp1 and Sp3 to the
GC-rich DNA elements. EMSA reactions were carried out with 4 lg
of nuclear extracts from AGS cells that were untreated (—) or
co-cultured with H. pylori 26695 strain for 3 hour (Hp). Labeled probes
represent GC-rich DNA elements of the human gastrin promoter and a
consensus AP1 binding sequence. The samples were incubated with
antibodies against Sp3 or Sp1 as indicated. Arrows indicate the
supershifted Sp1 and Sp3 DNA complexes.
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outcomes for infected patients, and the presence or
absence of these factors can alter the regulatory effect
on cells as well [10,47,48]. Specifically, H. pylori strains
that lack CagA tend to induce less inflammation and
are less commonly associated with the development of
ulcers and adenocarcinoma [49,50].
The bacterial virulence factors, CagA and VacA, were
not required for an increase in gastrin mRNA, but
rather other yet to be determined components of the
live bacteria were required to induce gastrin through
activation of MAPK signaling. Indeed, Helicobacter lipo-
polysaccharides have recently been shown to activate
the ERK MAPK [51] whereas CagA and VacA activate
host genes through the NFjB pathway [40,52]. Further
Cag3 has recently been shown to be a non-CagA, non-
VacA protein component of the T4S system that possi-
bly activates a distinctive signal transduction pathway
[53]. Therefore, we concluded that Helicobacter stimu-
lates gastrin through a general bacterial factor, such as
an outer membrane protein, or lipopolysaccharide as
opposed to a virulence factor expressed from a pathoge-
nicity island not present in all bacteria. Helicobacter LPS
stimulation of gastrin release from primary G cells was
partially inhibited by the ERK inhibitor PD98059 sup-
porting LPS as one candidate [26]. Documenting that
H. pylori stimulated transcriptional initiation permitted
mapping of the DNA elements mediating the induction.
We found that a CCACCC (GC-rich) binding motif,
mediated gastrin promoter activation. More impor-
tantly, we showed that H. pylori-induced MAPK signal-
ing induced binding of transcription factors Sp1 and
Sp3 to the GC-rich element at )109 bp upstream from
the transcription start site of the human gastrin gene,
but not at the )68 GC-rich element previously shown
to mediate EGF responsiveness [54]. Although the )68
GC-rich element binds Sp1, the induction of gastrin
gene transcription by EGF through ERK signaling is
achieved by phosphorylation of Sp1 [31] rather than
inducible binding of Sp1 to the )68 GC-rich site (gERE)
[32]. Activation of the EGF receptor by H. pylori has
also been reported for immortalized human gastric cells
[44]. H. pylori induction of gastrin gene expression and
secretion might retrospectively explain the observations
from the 1960s of duodenal ulcer patients exhibiting
parietal cell hyperplasia and enhanced acid secretion
[55,56]. Furthermore, in some colorectal cancers, muta-
tions in Ki-ras, which signals through ERK kinase, were
found in tumors with elevated levels of gastrin [30].
Thus, collectively, our findings demonstrate that
H. pylori can directly induce gastrin gene expression
and reiterates the idea that activation of MAPK signal-
ing is the primary proximal signaling mechanism for
induction of gastrin gene expression, an event that
might also impact the ability of the bacteria to promote
transformation.
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